Home › Asset managers › PENN SERIES FUNDS INC › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal PENN SERIES FUNDS INC voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,636 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | PENN SERIES FUNDS INC voted | Funds |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics SA | November 11, 2024 | Approving amendments to Article 4a of the articles of association to increase the Company's capital range The Board of Directors proposes that the amendments to Article 4a of the articles of association to increase the Company's capital range be approved. | Capital Structure | Board | AGAINST | 1 | |
| ADC Therapeutics SA | November 11, 2024 | Approving amendments to Article 4c of the articles of association to Increase the Company's conditional share capital for financing, acquisitions and other purposes The Board of Directors proposes that the amendments to Article 4c of the articles of association to increase the Company's conditional share capital for financing, acquisitions and other purposes be approved. | Capital Structure | Board | AGAINST | 1 | |
| ADC Therapeutics SA | June 3, 2025 | Approving amendments to article 4b of the articles of association to increase the Company's conditional share capital for employee participation The Board of Directors is proposing that the amendments to article 4b paragraph 1 of the articles of association to increase the Company's conditional share capital for employee participation from 9,547,482 common shares (CHF 763,798.56) to 12,776,259 common shares (CHF 1,022,100.72) be approved, as follows (amendment underlined for ease of reference): "The share capital may be increased in an amount not to exceed CHF 1,022,100.72 through the issuance of up to 12,776,259 fully paid in registered shares with a par value of CHF 0.08 per share through the direct or indirect issuance of shares, or through the exercise or mandatory exercise of rights to acquire shares or through obligations to acquire shares, which were granted to or imposed on members of the Board of Directors, members of the executive management, employees, contractors or consultants of the Company or its group companies, or other persons providing services to the Company or its group companies." | Capital Structure | Board | AGAINST | 1 | |
| ADC Therapeutics SA | June 3, 2025 | Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Board of Directors is proposing that an amendment to increase the number of shares authorized under 2019 Equity Incentive Plan be approved. | Compensation | Board | AGAINST | 1 | |
| ADC Therapeutics SA | June 3, 2025 | Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for the period between the Annual Meeting and the 2026 annual general meeting of Shareholders be set at $2,300,000. | Compensation | Board | AGAINST | 1 | |
| ADMA Biologics, Inc. | June 4, 2025 | To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S. | Director Elections | Board | WITHHOLD | 1 | |
| ADT Inc. | May 21, 2025 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| AEON Co., Ltd. | May 28, 2025 | Elect Director Okada, Motoya | Director Elections | Board | AGAINST | 1 | |
| AEON Co., Ltd. | May 28, 2025 | Elect Director Tsukamoto, Takashi | Director Elections | Board | AGAINST | 1 | |
| AG Mortgage Investment Trust, Inc. | May 5, 2025 | Election of Directors: Nicholas Smith | Director Elections | Board | WITHHOLD | 1 | |
| AMC Networks Inc. | June 5, 2025 | Election of the following nominees as Directors: Leonard Tow | Director Elections | Board | WITHHOLD | 1 | |
| AMC Networks Inc. | June 5, 2025 | Vote on Proposal to Approve the Company's Amended and Restated 2016 Employee Stock Plan | Compensation | Board | AGAINST | 1 | |
| AMC Networks Inc. | June 5, 2025 | Vote on Proposal to Approve the Company's Redomestication to the State of Nevada by Conversion | Extraordinary Transactions | Board | AGAINST | 1 | |
| AMETEK, Inc. | May 7, 2025 | Election of Directors for a term of three years: Dean Seavers | Director Elections | Board | AGAINST | 1 | |
| ANA HOLDINGS INC. | June 27, 2025 | Appoint Statutory Auditor Kikuchi, Shin | Compensation | Board | AGAINST | 1 | |
| ANA HOLDINGS INC. | June 27, 2025 | Elect Director Katanozaka, Shinya | Director Elections | Board | AGAINST | 1 | |
| ANSYS, Inc. | June 27, 2025 | Election of Seven Directors for One-Year Terms: Ravi Vijayaraghavan | Director Elections | Board | AGAINST | 1 | |
| ANZ Group Holdings Limited | December 19, 2024 | Elect Christine Elizabeth O'Reilly as Director | Director Elections | Board | AGAINST | 1 | |
| APA Group | October 24, 2024 | Approve Conditional Spill Resolution | Compensation | Board | AGAINST | 1 | |
| APA Group | October 24, 2024 | Elect David Lamont as Director | Director Elections | Board | AGAINST | 1 | |
| APL Apollo Tubes Limited | September 26, 2024 | Reelect Ashok Kumar Gupta as Director | Director Elections | Board | AGAINST | 1 | |
| APL Apollo Tubes Limited | September 26, 2024 | Reelect Sanjay Gupta as Director | Director Elections | Board | AGAINST | 1 | |
| APL Apollo Tubes Limited | January 21, 2025 | Approve Reappointment and Remuneration of Sanjay Gupta as Chairman and Managing Director | Compensation | Board | AGAINST | 1 | |
| ASP Isotopes Inc. | November 20, 2024 | Approval of the Quantum Leap Energy LLC 2024 Equity Incentive Plan, as amended. | Compensation | Board | AGAINST | 1 | |
| ASP Isotopes Inc. | November 20, 2024 | Election of directors to serve as Class II directors for a three-year term: Duncan Moore, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| ASX Limited | October 28, 2024 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| AVITA Medical, Inc. | June 4, 2025 | To approve (a) the 2020 Omnibus Incentive Plan Amended and Restated (the "Plan"), the terms of which are summarized in this Proxy Statement; and (b) for purposes of ASX Listing Rule 7.2 Exception 13(b), which provides an exception to ASX Listing Rule 7.1, the issuance of the Company's equity securities under the Plan, in accordance with its terms and conditions, for a period of up to three years from the date of stockholder approval. | Compensation | Board | AGAINST | 1 | |
| AVITA Medical, Inc. | June 4, 2025 | To approve the grant of 10,022 restricted stock units to acquire shares of Common Stock and the grant of 4,295 options to acquire shares of Common Stock to Suzanne Crowe on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; | Compensation | Board | AGAINST | 1 | |
| AVITA Medical, Inc. | June 4, 2025 | To approve the grant of 10,022 restricted stock units to acquire shares of the Company's common stock ("Common Stock") and the grant of 4,295 options to acquire shares of Common Stock to Lou Panaccio on the terms and conditions set out in the Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; | Compensation | Board | AGAINST | 1 | |
| AVITA Medical, Inc. | June 4, 2025 | To approve the grant of 520,000 options to acquire shares of Common Stock to the Company's Chief Executive Officer, James Corbett, on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11; | Compensation | Board | AGAINST | 1 | |
| AZZ Inc. | July 9, 2024 | Election of Directors: Carol R. Jackson | Director Elections | Board | AGAINST | 1 | |
| Abacus Global Management, Inc. | June 12, 2025 | Election of the three Class II Director Nominees: Karla Radka | Director Elections | Board | WITHHOLD | 1 | |
| Abacus Global Management, Inc. | June 12, 2025 | Election of the three Class II Director Nominees: Mary Beth Schulte | Director Elections | Board | WITHHOLD | 1 | |
| AbbVie Inc. | May 9, 2025 | Election of Class I Directors: Brett J. Hart | Director Elections | Board | AGAINST | 1 | |
| AbbVie Inc. | May 9, 2025 | Election of Class I Directors: Edward J. Rapp | Director Elections | Board | AGAINST | 1 | |
| AbbVie Inc. | May 9, 2025 | Election of Class I Directors: Thomas C. Freyman | Director Elections | Board | AGAINST | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Elect Ayshah Al Hallami as Director | Director Elections | Board | ABSTAIN | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Elect Huseen Al Nuwees as Director | Director Elections | Board | ABSTAIN | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Elect Khalid Khouri as Director | Director Elections | Board | ABSTAIN | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Elect Sultan Al Dhahiri as Director | Director Elections | Board | ABSTAIN | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Elect Zayid Al Nahayan as Director | Director Elections | Board | ABSTAIN | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Ratify the Appointment of Ahmed Al Mazrouee as Director | Director Elections | Board | AGAINST | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Ratify the Appointment of Carlos Obeed as Director | Director Elections | Board | AGAINST | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Ratify the Appointment of Fatimah Al Naeemi as Director | Director Elections | Board | AGAINST | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Ratify the Appointment of Khaldoun Al Mubarak as Director | Director Elections | Board | AGAINST | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Ratify the Appointment of Khalid Al Suweedi as Director | Director Elections | Board | AGAINST | 1 | |
| Abu Dhabi Commercial Bank | February 27, 2025 | Ratify the Appointment of Saeed Al Mazrouee as Director | Director Elections | Board | AGAINST | 1 | |
| Accenture plc | February 6, 2025 | Appointment of the following nominees to the Board of Directors: Arun Sarin | Director Elections | Board | AGAINST | 1 | |
| Accenture plc | February 6, 2025 | Appointment of the following nominees to the Board of Directors: Julie Sweet | Director Elections | Board | AGAINST | 1 | |
| Acciona SA | June 25, 2025 | Advisory Vote on Remuneration Report | Compensation | Board | AGAINST | 1 | |
| Acciona SA | June 25, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| Acciona SA | June 25, 2025 | Reelect Carlo Clavarino as Director | Director Elections | Board | AGAINST | 1 | |
| Acciona SA | June 25, 2025 | Reelect Maite Arango Garcia-Urtiaga as Director | Director Elections | Board | AGAINST | 1 | |
| Accolade, Inc. | August 6, 2024 | Election of Directors: Michael Hilton | Director Elections | Board | WITHHOLD | 1 | |
| Accor SA | May 28, 2025 | Approve Compensation of Sebastien Bazin, Chairman and CEO | Compensation | Board | AGAINST | 1 | |
| Accor SA | May 28, 2025 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 | |
| Accor SA | May 28, 2025 | Reelect Asma Abdulrahman Al-Khulaifi as Director | Director Elections | Board | AGAINST | 1 | |
| Accor SA | May 28, 2025 | Reelect Isabelle Simon as Director | Director Elections | Board | AGAINST | 1 | |
| Accor SA | May 28, 2025 | Reelect Nicolas Sarkozy as Director | Director Elections | Board | AGAINST | 1 | |
| Accor SA | May 28, 2025 | Reelect Qionger Jiang as Director | Director Elections | Board | AGAINST | 1 | |
| Accor SA | May 28, 2025 | Reelect Sarmad Zok as Director | Director Elections | Board | AGAINST | 1 | |
| Accor SA | May 28, 2025 | Reelect Ugo Arzani as Director | Director Elections | Board | AGAINST | 1 | |
| Accton Technology Corp. | June 12, 2025 | Elect a Representative of Golden Tengis Co., Ltd, with Shareholder No. 192057, as Non-independent Director | Director Elections | Board | AGAINST | 1 | |
| Accuray Incorporated | November 21, 2024 | To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan. | Compensation | Board | AGAINST | 1 | |
| Achieve Life Sciences, Inc. | June 4, 2025 | To approve an amendment to our 2023 Non-Employee Director Equity Incentive Plan to increase the number of shares available for issuance thereunder. | Compensation | Board | AGAINST | 1 | |
| Acrivon Therapeutics, Inc. | June 13, 2025 | Election of Class III Directors: Santhosh Palani, Ph.D., C.F.A. | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Ho Yeon (Aaron) Lee | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Keun Chang (Kevin) Yoon | Director Elections | Board | WITHHOLD | 1 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Director Elections | Board | WITHHOLD | 1 | |
| Advantest Corp. | June 27, 2025 | Elect Director and Audit Committee Member Kurita, Yuichi | Director Elections | Board | AGAINST | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | Election of Class II Directors: Patrick Machado | Director Elections | Board | WITHHOLD | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | To approve the amendment and restatement of the Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan. | Compensation | Board | AGAINST | 1 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | To approve the amendment of certain outstanding stock options to reduce the exercise price per share to the closing price on the date of repricing. | Compensation | Board | AGAINST | 1 | |
| Aena S.M.E. SA | April 9, 2025 | Reelect Francisco Javier Marin San Andres as Director | Director Elections | Board | AGAINST | 1 | |
| AeroVironment, Inc. | September 27, 2024 | To elect the board of directors' three nominees as directors: Cindy Lewis | Director Elections | Board | AGAINST | 1 | |
| Aeroports de Paris ADP | May 15, 2025 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 | |
| Aerovate Therapeutics, Inc. | April 16, 2025 | To approve the Jade Biosciences, Inc. 2025 Stock Incentive Plan (the "Stock Plan Proposal" or "Proposal No. 5"); | Compensation | Board | AGAINST | 1 | |
| Aerovate Therapeutics, Inc. | April 16, 2025 | To approve the redomestication of Aerovate from the State of Delaware to the State of Nevada by conversion (the "Redomestication Proposal" or "Proposal No. 4"); | Extraordinary Transactions | Board | AGAINST | 1 | |
| Aeva Technologies, Inc. | June 20, 2025 | Election of Class I Directors: Stefan Sommer, Ph. D. | Director Elections | Board | WITHHOLD | 1 | |
| Agenus Inc. | June 17, 2025 | To approve a one-time exchange modification of options to purchase shares under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan. | Compensation | Board | AGAINST | 1 | |
| Agenus Inc. | June 17, 2025 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares. | Compensation | Board | AGAINST | 1 | |
| Agenus Inc. | June 17, 2025 | To elect Brian Corvese and Timothy Wright as Class I directors, for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Brian Corvese | Director Elections | Board | WITHHOLD | 1 | |
| Agilysys, Inc. | September 12, 2024 | Election of Directors: Michael A. Kaufman | Director Elections | Board | WITHHOLD | 1 | |
| Agios Pharmaceuticals, Inc. | June 18, 2025 | To elect each of the two Class III director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Jacqualyn A. Fouse, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Agree Realty Corporation | May 15, 2025 | To approve, by non-binding vote, executive compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| Air Liquide SA | May 6, 2025 | Reelect Aiman Ezzat as Director | Director Elections | Board | AGAINST | 1 | |
| Air Liquide SA | May 6, 2025 | Reelect Bertrand Dumazy as Director | Director Elections | Board | AGAINST | 1 | |
| Air Products and Chemicals, Inc. | January 23, 2025 | Election of Directors: Nominees RECOMMENDED by the company: Charles Cogut | Director Elections | Board | WITHHOLD | 1 | |
| Air Products and Chemicals, Inc. | January 23, 2025 | Election of Directors: Nominees RECOMMENDED by the company: Edward L. Monser | Director Elections | Board | WITHHOLD | 1 | |
| Air Products and Chemicals, Inc. | January 23, 2025 | Election of Directors: Nominees RECOMMENDED by the company: Lisa A. Davis | Director Elections | Board | WITHHOLD | 1 | |
| AirSculpt Technologies, Inc. | May 7, 2025 | Election of Directors: Dan Sollof | Director Elections | Board | AGAINST | 1 | |
| Airtac International Group | May 21, 2025 | Elect WANG SHIH CHUNG, with Shareholder No. F121821XXX, as Non-independent Director | Director Elections | Board | AGAINST | 1 | |
| Ajinomoto Co., Inc. | June 20, 2025 | Elect Director Matsuzawa, Takumi | Director Elections | Board | AGAINST | 1 | |
| Aker BP ASA | May 13, 2025 | Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive Rights | Capital Structure | Board | AGAINST | 1 | |
| Aker BP ASA | May 13, 2025 | Approve Remuneration of Auditors | Audit-related | Board | AGAINST | 1 | |
| Aker BP ASA | May 13, 2025 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 | |
| Aker BP ASA | May 13, 2025 | Reelect Anne Marie Cannon, Kjell Inge Rokke and Kate Thomson as Directors; Elect Niamh Staunton as Deputy Director for Kate Thomson | Director Elections | Board | AGAINST | 1 | |
| Alarm.com Holdings, Inc. | June 4, 2025 | To approve the Alarm.com Holdings, Inc. 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Aldeyra Therapeutics, Inc. | June 10, 2025 | Election of three Class II Directors: Richard H. Douglas, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Alerus Financial Corporation | May 8, 2025 | Election of Directors: John Uribe | Director Elections | Board | WITHHOLD | 1 |
← Previous Page 3 of 27 Next →
← Back to PENN SERIES FUNDS INC 2024-2025 overview
Built October 25, 2026 from SEC Form N-PX filings.